D
AxoGen, Inc.
AXGN
$17.69
-$0.12-0.67%
D
Sell
12/20/2024Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 12/20/2024 due to an increase in the total return index, solvency index and volatility index. The quick ratio increased from 1.98 to 2.13, and debt to equity declined from 0.54 to 0.52.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 12/20/2024 due to an increase in the total return index, solvency index and volatility index. The quick ratio increased from 1.98 to 2.13, and debt to equity declined from 0.54 to 0.52.
E
Sell
10/28/2024Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 10/28/2024 due to a decline in the volatility index.
D
Sell
10/11/2024Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 10/11/2024 due to a large increase in the total return index and volatility index.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 10/11/2024 due to a large increase in the total return index and volatility index.
E
Sell
8/20/2024Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 8/20/2024 due to a decline in the valuation index and total return index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 8/20/2024 due to a decline in the valuation index and total return index.
D
Sell
3/21/2024Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 3/21/2024 due to an increase in the valuation index and total return index.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 3/21/2024 due to an increase in the valuation index and total return index.
E
Sell
3/6/2024Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 3/6/2024 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 112.98% from $1.63M to -$211, the quick ratio declined from 2.1 to 1.85, and debt to equity increased from 0.52 to 0.53.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 3/6/2024 due to a decline in the growth index, solvency index and valuation index. Operating cash flow declined 112.98% from $1.63M to -$211, the quick ratio declined from 2.1 to 1.85, and debt to equity increased from 0.52 to 0.53.
D
Sell
2/15/2024Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 2/15/2024 due to an increase in the volatility index, total return index and growth index. Operating cash flow increased 456.85% from $292 to $1.63M, EBIT increased 41.68% from -$6.9M to -$4.03M, and earnings per share increased from -$0.16 to -$0.1.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 2/15/2024 due to an increase in the volatility index, total return index and growth index. Operating cash flow increased 456.85% from $292 to $1.63M, EBIT increased 41.68% from -$6.9M to -$4.03M, and earnings per share increased from -$0.16 to -$0.1.
E
Sell
10/18/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 10/18/2023 due to a decline in the volatility index and total return index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 10/18/2023 due to a decline in the volatility index and total return index.
D
Sell
9/29/2023Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 9/29/2023 due to an increase in the volatility index and valuation index.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 9/29/2023 due to an increase in the volatility index and valuation index.
E
Sell
9/13/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 9/13/2023 due to a decline in the volatility index and total return index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 9/13/2023 due to a decline in the volatility index and total return index.
D
Sell
8/24/2023Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 8/24/2023 due to an increase in the volatility index and valuation index.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 8/24/2023 due to an increase in the volatility index and valuation index.
E
Sell
8/9/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 8/9/2023 due to a decline in the total return index and volatility index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 8/9/2023 due to a decline in the total return index and volatility index.
D
Sell
7/31/2023Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 7/31/2023 due to an increase in the valuation index.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 7/31/2023 due to an increase in the valuation index.
E
Sell
6/23/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 6/23/2023 due to a decline in the valuation index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 6/23/2023 due to a decline in the valuation index.
D
Sell
6/8/2023Upgraded
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 6/8/2023 due to a noticeable increase in the growth index, volatility index and total return index. Total revenue increased 1.38% from $36.16M to $36.66M.
AxoGen, Inc. (AXGN) was upgraded to D- from E+ on 6/8/2023 due to a noticeable increase in the growth index, volatility index and total return index. Total revenue increased 1.38% from $36.16M to $36.66M.
E
Sell
3/15/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 3/15/2023 due to a large decline in the growth index, volatility index and valuation index. Earnings per share declined from -$0.1023 to -$0.1303, EBIT declined 15.51% from -$4.86M to -$5.61M, and total revenue declined 2.15% from $36.96M to $36.16M.
AxoGen, Inc. (AXGN) was downgraded to E+ from D- on 3/15/2023 due to a large decline in the growth index, volatility index and valuation index. Earnings per share declined from -$0.1023 to -$0.1303, EBIT declined 15.51% from -$4.86M to -$5.61M, and total revenue declined 2.15% from $36.96M to $36.16M.
D
Sell
3/14/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
AxoGen, Inc. (AXGN) was upgraded to D from D- on 2/23/2023 due to an increase in the valuation index.
D
Sell
2/8/2023Downgrade
AxoGen, Inc. (AXGN) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
AxoGen, Inc. (AXGN) was downgraded to D- from D on 2/8/2023 due to a decline in the valuation index.
D
Sell
6/21/2022Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from D- on 6/21/2022 due to an increase in the valuation index.
AxoGen, Inc. (AXGN) was upgraded to D from D- on 6/21/2022 due to an increase in the valuation index.
D
Sell
6/3/2022Downgrade
AxoGen, Inc. (AXGN) was downgraded to D- from D on 6/3/2022 due to a decline in the volatility index and valuation index.
AxoGen, Inc. (AXGN) was downgraded to D- from D on 6/3/2022 due to a decline in the volatility index and valuation index.
D
Sell
5/16/2022Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index.
E
Sell
5/13/2022Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 5/13/2022 due to a large decline in the growth index, solvency index and valuation index. Operating cash flow declined 629.92% from -$1.51M to -$11.05M, earnings per share declined from -$0.1271 to -$0.2745, and EBIT declined 111.47% from -$5.35M to -$11.32M.
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 5/13/2022 due to a large decline in the growth index, solvency index and valuation index. Operating cash flow declined 629.92% from -$1.51M to -$11.05M, earnings per share declined from -$0.1271 to -$0.2745, and EBIT declined 111.47% from -$5.35M to -$11.32M.
D
Sell
5/4/2022Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index.
E
Sell
5/1/2022Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 5/1/2022 due to a decline in the total return index.
D
Sell
4/21/2022Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 04/21/2022.
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 04/21/2022.
E
Sell
4/20/2022Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the total return index, solvency index and volatility index. The quick ratio declined from 4.72 to 4.21, and debt to equity increased from 0.45 to 0.46.
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 4/20/2022 due to a substantial decline in the total return index, solvency index and volatility index. The quick ratio declined from 4.72 to 4.21, and debt to equity increased from 0.45 to 0.46.
D
Sell
11/9/2021Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 11/09/2021.
AxoGen, Inc. (AXGN) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 11/8/2021 due to a major decline in the solvency index, volatility index and efficiency index. The quick ratio declined from 5.48 to 4.72, debt to equity increased from 0.44 to 0.45, and total capital declined 1.26% from $190.69M to $188.29M.
AxoGen, Inc. (AXGN) was downgraded to E+ from D on 11/8/2021 due to a major decline in the solvency index, volatility index and efficiency index. The quick ratio declined from 5.48 to 4.72, debt to equity increased from 0.44 to 0.45, and total capital declined 1.26% from $190.69M to $188.29M.
D
Sell
11/27/2018Downgrade
AxoGen, Inc. (AXGN) was downgraded to D from D+ on 11/27/2018 due to a large decline in the volatility index, total return index and efficiency index. Total capital declined 0.69% from $150.59M to $149.55M.
AxoGen, Inc. (AXGN) was downgraded to D from D+ on 11/27/2018 due to a large decline in the volatility index, total return index and efficiency index. Total capital declined 0.69% from $150.59M to $149.55M.
D
Sell
9/20/2018Downgrade
AxoGen, Inc. (AXGN) was downgraded to D+ from C- on 9/20/2018 due to a significant decline in the total return index and volatility index.
AxoGen, Inc. (AXGN) was downgraded to D+ from C- on 9/20/2018 due to a significant decline in the total return index and volatility index.
C
Hold
8/2/2018Upgraded
AxoGen, Inc. (AXGN) was upgraded to C- from D+ on 8/2/2018 due to a large increase in the total return index, solvency index and efficiency index. The quick ratio increased from 2.72 to 14.8, total capital increased 225.41% from $46.28M to $150.59M, and debt to equity declined from 1.13 to 0.
AxoGen, Inc. (AXGN) was upgraded to C- from D+ on 8/2/2018 due to a large increase in the total return index, solvency index and efficiency index. The quick ratio increased from 2.72 to 14.8, total capital increased 225.41% from $46.28M to $150.59M, and debt to equity declined from 1.13 to 0.
D
Sell
3/6/2018Upgraded
AxoGen, Inc. (AXGN) was upgraded to D+ from D on 3/6/2018 due to a major increase in the volatility index, solvency index and efficiency index. Debt to equity declined from 2.31 to 0.98, total capital increased 42.63% from $34.93M to $49.82M, and the quick ratio increased from 2.89 to 3.47.
AxoGen, Inc. (AXGN) was upgraded to D+ from D on 3/6/2018 due to a major increase in the volatility index, solvency index and efficiency index. Debt to equity declined from 2.31 to 0.98, total capital increased 42.63% from $34.93M to $49.82M, and the quick ratio increased from 2.89 to 3.47.
D
Sell
3/13/2017Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from D- on 3/13/2017 due to a noticeable increase in the growth index, solvency index and volatility index. Debt to equity declined from 22.65 to 1.63, operating cash flow increased 40.12% from -$2.38M to -$1.42M, and total revenue increased 1.82% from $11.21M to $11.41M.
AxoGen, Inc. (AXGN) was upgraded to D from D- on 3/13/2017 due to a noticeable increase in the growth index, solvency index and volatility index. Debt to equity declined from 22.65 to 1.63, operating cash flow increased 40.12% from -$2.38M to -$1.42M, and total revenue increased 1.82% from $11.21M to $11.41M.
D
Sell
3/11/2016Downgrade
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and efficiency index. Net income declined 21.24% from -$2.98M to -$3.61M, and total capital declined 8.09% from $36.71M to $33.74M.
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/11/2016 due to a major decline in the volatility index and efficiency index. Net income declined 21.24% from -$2.98M to -$3.61M, and total capital declined 8.09% from $36.71M to $33.74M.
D
Sell
4/14/2014Upgraded
AxoGen, Inc. (AXGN) was upgraded to D from D- on 4/14/2014 due to a noticeable increase in the volatility index.
AxoGen, Inc. (AXGN) was upgraded to D from D- on 4/14/2014 due to a noticeable increase in the volatility index.
D
Sell
3/27/2014Downgrade
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/27/2014 due to a significant decline in the solvency index, volatility index and growth index. Debt to equity increased from 5.91 to 185.68, the quick ratio declined from 18.47 to 10.47, and operating cash flow declined 17.75% from -$2.9M to -$2.38M.
AxoGen, Inc. (AXGN) was downgraded to D- from D on 3/27/2014 due to a significant decline in the solvency index, volatility index and growth index. Debt to equity increased from 5.91 to 185.68, the quick ratio declined from 18.47 to 10.47, and operating cash flow declined 17.75% from -$2.9M to -$2.38M.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
